NCT05730621View on ClinicalTrials.gov

A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 11, 2023

Primary Completion Date

February 28, 2024

Study Completion Date

February 28, 2024

Conditions
SarpogrelateBlood ViscosityPeripheral Arterial DiseaseCoronary Artery Disease
Interventions
DRUG

Sarpogrelate Sustained Release/Aspirin

Aspirin 100mg qd and Sarpogrelate Sustained Release 300mg qd for 12 weeks

DRUG

Aspirin

Aspirin 100mg qd for 12 weeks

Trial Locations (1)

11765

The Catholic University of Korea Uijeongbu St. Mary's Hospital, Uijeongbu-si

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY